Insider & Political Trading

Official filings, normalized for faster research

Previous-day view · Mon Sep 14 close. You are previewing the previous trading day. Subscribe to see today live and every other date — plans start at Delta, $39/mo. Sign up Sign in

Desk brief

AI Sep 14

The tape was heavily sell-skewed: 473 filings reported about $154.2M bought versus $745.9M sold, with only one congressional disclosure.

Two insider buying clusters — Cluster buying led the notable signals: four insiders bought roughly $671.5K of PMTS across four filers, while four bought about $992.1K of GPUS across four filers. PMTS GPUS

Multiple insider selling clusters — Selling clusters were broader and larger, including five insiders selling about $18.6M of CHYM, four selling $17.4M of DBX, seven selling $9.2M of COST, three selling $2.1M of IOT, and 11 selling $2.2M of LOGI. CHYM DBX COST IOT LOGI

Cascade added heavily to RSG — Cascade Investment, L.l.c. bought roughly $453.0M of RSG and was also flagged as a 10% owner adding about $453.4M. RSG was the most bought ticker over 14 days at about $695.1M from one filer. RSG L.l.c. Cascade Investment

Largest reported purchase — Over the past 14 days, Bluearc Capital Management, Llc reported the largest purchase at roughly $99.4M of PBLSX. The broader period remained sell-heavy, with about $1.4B bought versus $13.0B sold. PBLSX Llc Bluearc Capital Management

The filings to keep on the tape were the four-filer buying clusters in PMTS and GPUS versus the larger insider selling clusters in CHYM, DBX, COST, IOT, and LOGI. YPF remained the most sold ticker over 14 days at about $5.3B across 22 filers, followed by APGE at about $1.1B across nine filers.

AI-generated from the filings on this page — not financial advice.

Filings · Sep 14

1039

Latest about 13 hours ago

Disclosed buying · 14d

$1.37B

1080 purchases across 1465 tickers

Disclosed selling · 14d

$12.97B

6075 sales and dispositions

Tape lean · 14d

Heavy selling

Largest buy: PBLSX $99.38M

Disclosure flow

Value filed per session · last 60 days

Where the money went

By disclosed value · 14 days · click a bar for the filings

Most bought

Most sold

Signals

Fixed rules over the last 21 days — see each card for why it fired

Cluster selling CHYM

7 insiders sold $209.03M about 13 hours ago

Cluster selling PMTS

9 insiders sold $55.22M about 14 hours ago

Cluster selling DK

9 insiders sold $3.34M about 14 hours ago

Cluster selling ROIV

7 insiders sold $9.26M about 14 hours ago

Cluster selling PCOR

5 insiders sold $8.15M about 15 hours ago

Cluster selling THC

4 insiders sold $37.02M about 15 hours ago

Cluster buying PMTS

5 insiders bought $11.96M about 15 hours ago

$1M+ insider buy PMTS

Tricor Pmt25 Holdings Inc. bought $11.29M about 15 hours ago

10% owner adding PMTS

Tricor Pmt25 Holdings Inc. added $11.29M about 15 hours ago

Executive buy DVN

Gaspar Clay M bought $199.88K about 16 hours ago

Cluster buying GPUS

4 insiders bought $1.14M about 16 hours ago

Cluster selling FIGR

3 insiders sold $20.39M about 16 hours ago

Disclosure sentiment

Who is buying against who is selling · 90 days · −100 to +100

Accumulation

AMR 26 buys · 0 sells +100

AAT 17 buys · 0 sells +100

RCG 52 buys · 0 sells +100

SUJA 22 buys · 0 sells +100

DLHC 43 buys · 0 sells +100

UUU 32 buys · 0 sells +100

Distribution

UTHR 0 buys · 496 sells -100

CRWV 0 buys · 785 sells -100

DELL 0 buys · 651 sells -100

SE 0 buys · 468 sells -100

NET 0 buys · 277 sells -100

STX 0 buys · 240 sells -100

Bullish and bearish sectors

Net disclosed value · 30 days

Buying extends right, selling left. A company in more than one industry counts in each.

631 filings

Official insider and political disclosure transactions
Filed	Transaction	Issuer / asset	Reporting person	Qty / price	Value	Source
Sep 4, 2026 Same-day filing	Sale Sep 4, 2026	KRYS Krystal Biotech, Inc. Common Stock	Krishnan Krish S Insider President And CEO	3,143 shares @ $358.42 Direct ownership	$1.13M	SEC Form 4
Same filing as the row above	Sale Sep 4, 2026			405 shares @ $366.56 Direct ownership	$148.46K
Same filing as the row above	Sale Sep 4, 2026			520 shares @ $354.54 Direct ownership	$184.36K
Same filing as the row above	Sale Sep 4, 2026			2,010 shares @ $362.65 Direct ownership	$728.93K
Same filing as the row above	Sale Sep 4, 2026			3,297 shares @ $356.37 Direct ownership	$1.17M
Same filing as the row above	Sale Sep 4, 2026			573 shares @ $363.34 Direct ownership	$208.2K
Same filing as the row above	Sale Sep 4, 2026			2,029 shares @ $355.57 Direct ownership	$721.46K
Same filing as the row above	Sale Sep 4, 2026			2,266 shares @ $360.46 Direct ownership	$816.81K
Same filing as the row above	Sale Sep 4, 2026			1,214 shares @ $361.61 Direct ownership	$438.99K
Sep 4, 2026 Same-day filing	Buy Sep 4, 2026	ATRA Atara Biotherapeutics, Inc. Common Stock	Cherry Brian N Insider Director	104,166 shares @ $9.6 Direct ownership	$999.99K	SEC Form 4
Sep 4, 2026 1-day lag	Sale Sep 3, 2026	HNGE Hinge Health, Inc. Class A Common Stock	Robinson Elliott Insider Director	0 shares @ $0 Indirect ownership	$0	SEC Form 4
Same filing as the row above	Sale Sep 2, 2026			0 shares @ $0 Indirect ownership	$0
Sep 4, 2026 2-day lag	Disposition Sep 2, 2026	FRNM Freenome, Inc. Common Stock	Elliott Aaron Matthew Insider Chief Executive Officer	71,920 shares @ $15.25 Direct ownership	$1.1M	SEC Form 4
Sep 4, 2026 2-day lag	Exercise Sep 2, 2026	TRAX First Tracks Biotherapeutics, Inc. Stock Option (right to buy) on Common Stock	Ware J. Anthony Insider Director	10,694 shares @ $0 Direct ownership	$0	SEC Form 4
Same filing as the row above	Exercise Sep 2, 2026 Common Stock			39,265 shares @ $5.74 Direct ownership	$225.38K
Same filing as the row above	Sale Sep 2, 2026			39,265 shares @ $44.78 Direct ownership	$1.76M
Same filing as the row above	Exercise Sep 2, 2026 Stock Option (right to buy) on Common Stock			28,571 shares @ $0 Direct ownership	$0
Sep 4, 2026 1-day lag	Sale Sep 3, 2026	ARTV Artiva Biotherapeutics, Inc. Common Stock	Horan Christopher Insider Chief Tech Operations Officer	10,366 shares @ $11.16 Direct ownership	$115.64K	SEC Form 4
Sep 4, 2026 1-day lag	Sale Sep 3, 2026	ARTV Artiva Biotherapeutics, Inc. Common Stock	Bush Jennifer Insider COO, CLO, Compliance Officer	8,391 shares @ $11.16 Direct ownership	$93.61K	SEC Form 4
Sep 4, 2026 1-day lag	Sale Sep 3, 2026	ARTV Artiva Biotherapeutics, Inc. Common Stock	Banerjee Subhashis Insider Chief Medical Officer	1,100 shares @ $11.16 Direct ownership	$12.27K	SEC Form 4
Sep 4, 2026 1-day lag	Sale Sep 3, 2026	ARTV Artiva Biotherapeutics, Inc. Common Stock	Aslan Fred Insider Chief Executive Officer	61,888 shares @ $11.16 Direct ownership	$690.39K	SEC Form 4
Sep 4, 2026 1-day lag	Award Sep 3, 2026	PLX Protalix Biotherapeutics, Inc. Stock Option (Right to Buy) on Common Stock	Naos Yaron Insider Sr. VP & COO	112,000 shares @ $0 Direct ownership	$0	SEC Form 4
Same filing as the row above	Award Sep 3, 2026 Restricted Stock Units on Common Stock			56,000 shares @ $0 Direct ownership	$0
Sep 4, 2026 1-day lag	Award Sep 3, 2026	PLX Protalix Biotherapeutics, Inc. Restricted Stock Units on Common Stock	Elze Christian Insider Director	8,500 shares @ $0 Direct ownership	$0	SEC Form 4
Sep 4, 2026 1-day lag	Award Sep 3, 2026	PLX Protalix Biotherapeutics, Inc. Stock Options (Right to Buy) on Common Stock	Melincoff Gwen A Insider Director	17,000 shares @ $0 Direct ownership	$0	SEC Form 4

Krishnan Krish S Insider President And CEO

Sale

KRYS Krystal Biotech, Inc.

Calculated transaction value

$1.13M

Traded

Sep 4, 2026

Filed

Sep 4, 2026

Quantity / price

3,143 shares @ $358.42

SEC Form 4